NF-κB signaling pathway mediates the anti-tumor effect of Ginsenoside Rg1 in glioblastoma. [PDF]
Li S, Chang J, Chi B, Liu Y, Xiang J.
europepmc +1 more source
Ginsenoside Rg1 ameliorates renal ischemia-reperfusion injury by inhibiting FABP1-regulated Nrf2/HO-1 pathway. [PDF]
Chang X +5 more
europepmc +1 more source
Ginsenoside Rg1 attenuates experimental periodontitis via modulating the PI3K/AKT pathway and TLR2 expression. [PDF]
Pu Y, Chen L, Wang D, Pan Y, Guo L.
europepmc +1 more source
Targeting mitochondrial quality control: Ginsenoside Rg1 as a therapeutic candidate for neuromuscular diseases. [PDF]
Cai X +6 more
europepmc +1 more source
Ginsenoside Rg1 alleviated testicular and sperm damage in rats exposed to bisphenol A. [PDF]
Abdi F +5 more
europepmc +1 more source
Ginsenoside Rg1 ameliorates lipopolysaccharide-induced depressive-like behaviors in mice by attenuating neuroinflammation and neuronal damage. [PDF]
Zhang L +6 more
europepmc +1 more source
Ginsenoside Rg1 Attenuates Renal Ischemia-Reperfusion Injury and Fibrosis by Suppressing Pro-Inflammatory Macrophage Activation. [PDF]
Huang Y +8 more
europepmc +1 more source
Ginsenoside Rg1 delays the senescence of adipose-derived stem cells: network pharmacology and experimental validation. [PDF]
Fang Y +7 more
europepmc +1 more source
Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine. [PDF]
Cortés H +13 more
europepmc +1 more source
Ginsenoside Rg1 antagonizes diabetic osteoporosis by regulating ferroptosis via mitochondrial membrane potential in H-type vascular endothelial cells. [PDF]
Chen M +7 more
europepmc +1 more source

